Our global Pharmaceuticals portfolio includes more than 50 key marketed products, many of which are innovative leaders in their therapeutic areas.
Novartis cardiovascular-metabolic therapeutic teams are passionate about research, development and quality manufacturing of novel therapies and solutions to reduce the burden of diseases in communities around the world. We focus our efforts on diseases that negatively affect the heart, kidney, liver and blood vessels with the goal of better patient outcomes.
For more information about Heart Failure, raise awareness and join our Public Awareness campaign please visit KeepItPumping.com
Novartis has a strong 60-year history in neuroscience. We currently offer patients and physicians a large drug portfolio encompassing Multiple Sclerosis, Alzheimer’s disease, Parkinson’s Disease, Epilepsy and ADHD, and have a promising pipeline in Multiple Sclerosis, Alzheimer’s disease and Neuromuscular therapies. In our research, we leverage advances in human genetics, new imaging technologies and other novel approaches to better understand brain disorders and continue bringing pioneering drugs to patients worldwide.
For more information about our outreach to Multiple Sclerosis patients, please visit www.livinglikeyou.com.
Novartis Oncology is a leader in driving the practice of precision oncology treatment. Precision oncology is the evolving understanding of how cancers develop on a genomic level and our ability to develop drugs that hone in on those targets – ultimately leading to better patient outcomes. Our research, driven by a distinctive scientific and clinical strategy, focuses on unmet medical needs and disease pathways.
For more information on our commitment to transform the way people live with cancer and targeted diseases, visit www.novartisoncology.com.
Cell and Gene Therapy
Novartis Pharmaceuticals has created a dedicated unit focused on the development and commercialization of cell and gene therapies. The cell therapy portfolio aims to transform medical practice and potentially cure some patients suffering from a variety of life-threatening diseases including bloodborne cancers, sickle cell disease, thalassemias and other diseases of the blood by replacing, repopulating or resetting the immune system.
Pain and Bone
In the past years we have developed many novel molecules among which some became tested by time and trusted by millions. Together these brands are named as Established Medicines. Our EM portfolio focuses on pain management, muscle spasm and epilepsy. With our brands we are helping patients to bring back their smile by reducing pain, inflammation, muscle spasm and episodes of epilepsy.